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1. Introduction 
It has been reported that the antimicrobial ctivity 
of the thermophihc fungus, Mucor pusiZius, resides 
in the unique peptide produced by this organism in 
liquid culture [ 1 ] . Tha peptide sillucm is actwe only 
against gram-positive bacteria nd its apparent site of 
action 1s at the level of RNA metabolism [2,3]. 
The antibiotic sillucin has been described m detti 
[3] , and is a 30 residue peptlde containing 4 dlsulfide 
bridges, no methlonine, phenylalanine or hlstidine 
residues. A family of related peptides IS also synthe- 
sized by different strams of M. miehei, another 
thermophllic species m the genus Mucor [3] . 
As a beginning to the elucidation of the structure- 
fun&on correlations of these unique fungal antibiotic 
peptides, we report here the primary ammo acid 
sequence of sillucm. 
2. Methods 
The production, lsolatlon and purification of the 
antunicrobial peptide were done by the methods in 
[ 1,3] . Purity was Judged by polyacrylamide gel 
electrophoresls and by N-terminal analyses of the 
intact carboxymethylated peptlde by the automated 
Edman procedure. Punfied peptlde, 2 pmol, were 
carboxymethylated asin [4]. The extent of modifica- 
tlon was assessed by ammo acid analyses and was 
found to be essentially quantitative. 
Tryptic and carboxypeptldase Y [S] digestions 
were done on the reduced, carboxymethylated peptide. 
ElsevlerlNorth-Holland Biomedical Press 
Tryptic fragments were isolated from DEAE-Sephadex 
eqmlibrated with 10 mM Tris-HCl (pH 8.2) using a 
linear salt gradient from O-O.2 M NaCI. 
Automated sequencer degradations of the intact 
R [ 14C] CM-peptide or RCM-peptide and of the tryptic 
fragments were done on a Beckman sequencer model 
890B (updated) using essentially the peptide program 
in [6]. Horse heart apocytochrome c (2-3 mg/run), 
Isolated as m [7], or polybrene (3 mglrun) [8,9] was 
included in each run to reduce extractive losses of 
the peptlde. Phenylthiohydantoin derivatives were 
analyzed by TLC [lo] , GLC [ 1 I] or by back hydro- 
lysis with 55% HI at 130°C for 24 h. Ammo acid 
analyses were performed on a Beckman ammo aad 
analyzer model 119. 
3. Results and discussion 
The separation of the tryptlc fragments of the 
carboxymethylated peptide on DEAE-Sephadex 1s 
Illustrated in fig.1. Excellent separation was achieved 
with the dodecapeptide, T-2 fragment, elutmg only 
upon addition of 1 M NaCl. The composition, 
N-termmals, and recovery ields of each tryptlc 
peptide are shown in table 1. T4, a tripeptide, con- 
tamed no Lys or Arg, and therefore was assigned as 
the carboxyterminal fragment. 
The carboxytermmal sequence, as well as the over- 
lap of T-3 and T-4, were determined by degradation 
with carboxypeptidase Y. Automated Edman degrada- 
tion on the mtact RCM-peptide through 16 cycles 
established the sequence of the N-termmal portion of 
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Frg.1. Elutton profile of the separatron of the tryptrc pep- 
trdes of sdlucm on DEAE-Sephadex (0 01 M Tns-HCl 
@H 8.2) wrth linear salt gradient from O-O.2 M NaCl) The 
pooled fractions are desrgnated by the bars under each peak. 
the modrfied peptrde and allowed the alignment of 
the tryptic peptides (T-l -T-2-T-3-T4). The sequence 
of residues 1l-22 was established by an automated 
sequencer run of T-2 through 10 cycles. The tryptrc 
pentapeptrde, T-3, was sequenced through 4 cycles by 
automated Edman degradation mthe presence of 
apocytochrome c.
The complete amino acid sequence ofthe,!5carboxy- 
methylated antimrcrobial peptide is shown m fig.2 
and accounts for the ammo acid composition and the 
mol. wt 3400, estimated by analytical ultracentnfuga- 
tron, reported [3]. 
The ammo acid sequence indicates the possibrhty 
-m_,-~-D~-_,-_,~-~~-~-, 
5 IO----W 
A~~-CMC-LO~~P~O-A~~-SO~-~C-V~~~~-LY~_G-CMC-G~~- 
I T-l 
=S,,,~ 
--z- 30 
A~x-S.r-Gly-Tyr-Trp-CMC-Arg-Gln-CMC-Gly-ii~-Ly~-Tyr-Thr-CMC 
---- CCtCC- 
T-Z-_- T-3- c--.4- 
Ftg 2. The complete ammo acid sequence of silhtcm. 
(+) Designated residues identrfied by automated sequencer 
runs on the entrre carboxymethylated peptrde (-) Indrcates 
sequencer un on the isolated tryptrc peptrde (+) Denotes 
residue(s) identified by digestion with carboxypeptrdase Y 
on the mtact modified pepttde and (-) on the isolated 
tryptic fragments. 
Table 1 
Ammo acid composition of the tryptic peptides of carboxymethylated antrmrcrobral 
peptrde from M. pusillus 
Amino acid Total T-l T-2 T-3 T-4 
Asp 
Thr 
Ser 
Glu 
Pro 
CJY 
Ala 
cysa 
Val 
Be 
Leu 
Tyr 
LYS 
Arg 
Trp 
Total residues 
Sequence position 
% Yield 
NH, -termmus 
2 
1 
3 
1 
1 
4 
1 
8 
1 
1 
1 
2 
2 
1 
1 
- 
30 
1.0 (1) 
1.9 (2) 
1.1 (1) 
1.0 (1) 
1.5 (2) 
0 9 (1) 
0 9 (1) 
1.1 (1) 
--- 
(10) 
l-10 
97 
Ala 
I.1 (1) 
1.0 (1) 
2.9 (3) 
3 7 (4) 
1.0 (1) 
1 l(l) 
1.0 (1) 
1 0 (1) 
0 7 (1) 0 7 (1) 
0.9 (1) 
0.9 (1) 
1 1(l) 
1.0 (1) 
0.4 (1) 
(12) (5) 
11-22 23-21 
82 91 
CLY Gin 
(3) 
28-30 
90 
Tyr 
a Determined as carboxymethylcysteme 
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of only one acidic residue at position 16. This explains 
the cathodrc electrophoretic migration of sillucin 
even at basrc onditions (pH -10). 
Finally, the thermal stability and the inaccessibility 
of the tryptophan residue to formylation under non- 
reducmg conditions reflects the compact structure 
mrposed by the 4 drsulfide bridges present in the 
native peptide [3]. 
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